These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5807479)

  • 1. Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755.
    Laster WR; Mayo JG; Simpson-Herren L; Griswold DP; Lloyd HH; Schabel FM; Skipper HE
    Cancer Chemother Rep; 1969 Jun; 53(3):169-88. PubMed ID: 5807479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of cyclophosphamide, ribo-azauracil and mercaleukin pretreatment on experimental metastasizing in a syngenic tumor-host system. I. Spontaneous breast carcinoma of the mouse].
    Nowak C; Elbe B; Arnold W; Bender E
    Arch Geschwulstforsch; 1973; 41(1):1-11. PubMed ID: 4700692
    [No Abstract]   [Full Text] [Related]  

  • 3. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
    Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
    Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of mitotic circadian rhythm of a transplantable mammary carcinoma after 35 generations: its bearing on the success of treatment with endoxan.
    Badran AF; Echave Llanos JM
    J Natl Cancer Inst; 1965 Aug; 35(2):285-90. PubMed ID: 5827236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy experiments on autochthonic mammary carcinoma in rats].
    Fretz J; Rohde W; Schmähl D; Thomas C
    Arzneimittelforschung; 1969 Aug; 19(8):1291-5. PubMed ID: 5820295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cyclophosphamide on the ganglioside content and profile in metastasizing and nonmetastasizing mammary carcinoma in mice].
    Novikov AM; Kozlov AM; Bassalyk LS
    Biull Eksp Biol Med; 1985 Jul; 100(7):76-8. PubMed ID: 4016245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of chemotherapy and immunotherapy in the treatment of carcinoma of the mammary gland in mice (author's transl)].
    Turić M; Malenica B; Rogan-Grgas J; Milas L
    Lijec Vjesn; 1978 May; 100(5):289-94. PubMed ID: 682831
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysosomes in mice mammary tumors treated with cyclophosphamide. Distribution related to course of disease.
    Anton E; Brandes D
    Cancer; 1968 Mar; 21(3):483-500. PubMed ID: 5637954
    [No Abstract]   [Full Text] [Related]  

  • 9. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.
    Sluyser M; De Goeij CC; Evers SG
    J Natl Cancer Inst; 1981 Feb; 66(2):327-30. PubMed ID: 6935481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antineoplastic activity of lambdamycin in different murine test models compared with cyclophosphamide, 6-mercaptopurine and 5-fluorouracil (author's transl)].
    Gutsche W; Wohlrabe K; Jungstand W; Fleck WF
    Arch Geschwulstforsch; 1981; 51(5):398-404. PubMed ID: 7197906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
    Scheiber C; Kiss R; De Launoit Y; Frühling J
    Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibility of using an alkylating agent in radiotherapy of mammary carcinoma in C3H-He mice.
    Urano M; Tanaka N; Hayashi S
    Gan; 1972 Aug; 63(4):491-4. PubMed ID: 5081625
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of treatment with cyclophosphamide on hormone-dependent and hormone-independent tumor cells in transplanted GR mouse mammary tumors.
    Sluyser M; Benckhuysen C
    Cancer Treat Rep; 1977 Aug; 61(5):861-7. PubMed ID: 890694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
    Kimball AP; LePage GA; Allinson PS
    Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
    [No Abstract]   [Full Text] [Related]  

  • 16. Different effects of cyclophosphamide in vivo and phosphamide mustard in vitro on two cell clones of chemically induced mammary carcinoma of the rat.
    Angres G; Scherf HR
    J Cancer Res Clin Oncol; 1989; 115(2):203-6. PubMed ID: 2715170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-tumor sensitivity matching procedure using diffusion chambers in vivo.
    Cain BF; Calveley SB; Boreham BA; West C; Price NA; Walker DJ; Churchouse MJ
    Cancer Chemother Rep; 1974; 58(2):189-205. PubMed ID: 4857364
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-asparaginase (NSC-109,229) on transplantable and spontaneous tumors from mice and rats.
    Sugiura K
    Cancer Chemother Rep; 1969 Jun; 53(3):189-94. PubMed ID: 5807480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the content and composition of gangliosides of tumors as affected by chemotherapeutic agents].
    Kozlov AM; Novikov AM; Bassalyk LS; Sof'ina ZP
    Eksp Onkol; 1984; 6(5):62-6. PubMed ID: 6510346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induced resistance of experimental tumors to nitrosomethylurea].
    Krutova TV; Ostrovskaia LA
    Vopr Onkol; 1982; 28(11):48-52. PubMed ID: 7147832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.